Literature DB >> 7948527

Antiretroviral therapy for infection due to human immunodeficiency virus in children.

P A Pizzo1, C Wilfert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7948527     DOI： 10.1093/clinids/19.1.177

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

Review 1.  Tolerabilities of antiretrovirals in paediatric HIV infection.

Authors:  Daniel Avi Lemberg; Pamela Palasanthiran; Michele Goode; John B Ziegler
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.

Authors:  J C Adkins; D H Peters; D Faulds
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

3.  L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes.

Authors:  W Z Ho; S E Starr; A Sison; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 4.  Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment.

Authors:  C Exhenry; D Nadal
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

5.  Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children.

Authors:  W Hughes; J A McDowell; J Shenep; P Flynn; M W Kline; R Yogev; W Symonds; Y Lou; S Hetherington
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.